ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Gonadotropin therapy in male infants and adolescents with HH
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 266921" data-attributes="member: 13851"><p>[MEDIA=youtube]9KMv9nryRYY[/MEDIA]</p><p></p><p><strong><em>This video discusses the use of gonadotropin therapy in male infants and adolescents with hypogonadism. Dr. Sasha Howard from Queen Mary University of London explains the evidence and best practices for this treatment. She emphasizes the importance of early diagnosis and treatment to improve patient outcomes and fertility.</em></strong></p><p><strong></strong></p><p><strong>2023 Anne Klibanski Visiting Lecture Series 08 with Dr. Sasha Howard</strong></p><p></p><ul> <li data-xf-list-type="ul"><em><em>Dr. Sasha Howard discusses the use of gonadotropin therapy in males with hypogonadism.</em></em></li> <li data-xf-list-type="ul"><em><em>The Ann Klibanski Visiting Scholar Award is an opportunity for faculty to gain recognition and expand their network.</em></em></li> <li data-xf-list-type="ul"><em><em>The lecture series fosters collaborations across national and international institutions.</em></em></li> <li data-xf-list-type="ul"><em><em>Collaborations have included institutions like Queen Mary University of London.</em></em></li> <li data-xf-list-type="ul"><strong><em><em><strong>The use of gonadotropin therapy in male patients with hypogonadism leads to improved testicular and penile size, serum testosterone, and spermatogenesis.</strong></em></em></strong></li> <li data-xf-list-type="ul"><strong><em><em><strong>Combination therapy with FSH and HCG appears to have better outcomes than HCG monotherapy.</strong></em></em></strong></li> <li data-xf-list-type="ul"><strong><em><em><strong>The treatment is well-tolerated with minimal adverse effects.</strong></em></em></strong></li> <li data-xf-list-type="ul"><strong><em><em><strong>Gonadotropin therapy in infancy is effective in achieving testicular volume increase, testicular descent, and improved biochemical parameters.</strong></em></em></strong></li> <li data-xf-list-type="ul"><em><em>Further research and data collection are needed to determine the best practices and long-term outcomes of gonadotropin therapy in both adolescence and infancy.</em></em></li> <li data-xf-list-type="ul"><strong><em><em><strong>The use of gonadotropin therapy should be considered in patients with severe hypogonadism who are unresponsive to testosterone treatment or desire testicular development and sperm banking.</strong></em></em></strong></li> </ul><p></p><p></p><p>[ATTACH=full]37993[/ATTACH]</p><p>[ATTACH=full]37994[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 266921, member: 13851"] [MEDIA=youtube]9KMv9nryRYY[/MEDIA] [B][I]This video discusses the use of gonadotropin therapy in male infants and adolescents with hypogonadism. Dr. Sasha Howard from Queen Mary University of London explains the evidence and best practices for this treatment. She emphasizes the importance of early diagnosis and treatment to improve patient outcomes and fertility.[/I] 2023 Anne Klibanski Visiting Lecture Series 08 with Dr. Sasha Howard[/B] [LIST] [*][I][I]Dr. Sasha Howard discusses the use of gonadotropin therapy in males with hypogonadism.[/I][/I] [*][I][I]The Ann Klibanski Visiting Scholar Award is an opportunity for faculty to gain recognition and expand their network.[/I][/I] [*][I][I]The lecture series fosters collaborations across national and international institutions.[/I][/I] [*][I][I]Collaborations have included institutions like Queen Mary University of London.[/I][/I] [*][B][I][I][B]The use of gonadotropin therapy in male patients with hypogonadism leads to improved testicular and penile size, serum testosterone, and spermatogenesis.[/B][/I][/I][/B] [*][B][I][I][B]Combination therapy with FSH and HCG appears to have better outcomes than HCG monotherapy.[/B][/I][/I][/B] [*][B][I][I][B]The treatment is well-tolerated with minimal adverse effects.[/B][/I][/I][/B] [*][B][I][I][B]Gonadotropin therapy in infancy is effective in achieving testicular volume increase, testicular descent, and improved biochemical parameters.[/B][/I][/I][/B] [*][I][I]Further research and data collection are needed to determine the best practices and long-term outcomes of gonadotropin therapy in both adolescence and infancy.[/I][/I] [*][B][I][I][B]The use of gonadotropin therapy should be considered in patients with severe hypogonadism who are unresponsive to testosterone treatment or desire testicular development and sperm banking.[/B][/I][/I][/B] [/LIST] [ATTACH type="full" alt="Screenshot (29550).png"]37993[/ATTACH] [ATTACH type="full" alt="Screenshot (29551).png"]37994[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Gonadotropin therapy in male infants and adolescents with HH
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top